Finally, we found that genetic ablation of plasminogen or PAs prevents the formation of radiodermatitis in mice and that the inhibition of plasminogen activation by TXA significantly decreases the severity of radiodermatitis in plg+/+ mice and prevents radiodermatitis in plg+/− mice. The gene discussed is PLG; the disease is radiodermatitis.